Complicated granulomatous colitis in a Japanese patient with Hermansky–Pudlak syndrome, successfully treated with infliximab
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
We report a case of refractory granulomatous colitis and perineal fistulas complicated by Hermansky–Pudlak syndrome (HPS) that was successfully treated by repeated infusions of infliximab. The patient was a mentally retarded 30-year-old Japanese man who was diagnosed with HPS based on albinism, nystagmus, and a history of bleeding diathesis in his childhood. Since he was 28 years old, he had suffered from severe granulomatous colitis with perineal fistulas, which had been resistant to medical treatment including sulfasalazine, mesalamine, and steroids. At 30 years of age, diverting colostomy was performed aiming at subsiding severe bleeding and a perianal abscess. Three months after surgery, the patient developed sudden onset of fever, chills, and bloody bowel movements. Then, infliximab was administered at a dose of 5 mg/kg, and most of symptoms were relieved within 48 h of administration. The patient obtained remission with a constant daily dosage of azathioprine and a monthly dosage of infliximab. The present case is the first report of complicated granulomatous colitis with HPS, which was successfully treated with infliximab in Japan.
- Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood. 1959;14:162–9.
- Garay SM, Gardella JE, Fazzini EP, Goldring RM. Hermansky–Pudlak syndrome. Pulmonary manifestations of a ceroid storage disorder. Am J Med. 1979;66:737–47. CrossRef
- Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. Hermansky–Pudlak syndrome with granulomatous colitis. Ann Intern Med. 1980;92:20–3.
- Sherman A, Genuth L, Hazzi CG, Balthazar EJ, Schinella RA. Perirectal abscess in the Hermansky–Pudlak syndrome. Am J Gastroenterol. 1989;84:552–6.
- de Leusse A, Dupuy E, Huizing M, Danel C, Meyer G, Jian R, et al. Ileal Crohn’s disease in a woman with Hermansky–Pudlak syndrome. Gastroenterol Clin Biol. 2006;30:621–4. CrossRef
- Erzin Y, Cosgun S, Dobrucali A, Tasyurekli M, Erdamar S, Tuncer M. Complicated granulomatous colitis in a patient with Hermansky–Pudlak syndrome, successfully treated with infliximab. Acta Gastroenterol Belg. 2006;69:213–6.
- Grucela AL, Patel P, Goldstein E, Palmon R, Sachar DB, Steinhagen RM. Granulomatous enterocolitis associated with Hermansky–Pudlak syndrome. Am J Gastroenterol. 2006;101:2090–5. CrossRef
- Huizing M, Anikster Y, Gahl WA. Hermansky–Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost. 2001;86:233–45.
- Hussain N, Quezado M, Huizing M, Geho D, White JG, Gahl W, et al. Intestinal disease in Hermansky–Pudlak syndrome: occurrence of colitis and relation to genotype. Clin Gastroenterol Hepatol. 2006;4:73–80. CrossRef
- Mahadeo R, Markowitz J, Fisher S, Daum F. Hermansky–Pudlak syndrome with granulomatous colitis in children. J Pediatr. 1991;118:904–6. CrossRef
- Sandberg-Gertzen H, Eid R, Jarnerot G. Hermansky–Pudlak syndrome with colitis and pulmonary fibrosis. Scand J Gastroenterol. 1999;34:1055–6. CrossRef
- Witkop CJ, Nunez Babcock M, Rao GH, Gaudier F, Summers CG, Shanahan F, et al. Albinism and Hermansky–Pudlak syndrome in Puerto Rico. Bol Asoc Med P R. 1990;82:333–9.
- Oh J, Ho L, Ala-Mello S, Amato D, Armstrong L, Bellucci S, et al. Mutation analysis of patients with Hermansky–Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet. 1998;62:593–8. CrossRef
- Ito S, Suzuki T, Inagaki K, Suzuki N, Takamori K, Yamada T, et al. High frequency of Hermansky–Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein. J Invest Dermatol. 2005;125:715–20. CrossRef
- Lim WC, Hanauer SB. Emerging biologic therapies in inflammatory bowel disease. Rev Gastroenterol Disord. 2004;4:66–85.
- Hazzan D, Seward S, Stock H, Zisman S, Gabriel K, Harpaz N, et al. Crohn’s-like colitis, enterocolitis and perianal disease in Hermansky–Pudlak syndrome. Colorectal Dis. 2006;8:539–43. CrossRef
- Witkop CJ Jr, Wolfe LS, Cal SX, White JG, Townsend D, Keenan KM. Elevated urinary dolichol excretion in the Hermansky–Pudlak syndrome. Indicator of lysosomal dysfunction. Am J Med. 1987;82:463–70. CrossRef
- Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky–Pudlak syndrome). N Engl J Med. 1998;338:1258–64. CrossRef
- Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999;340:1398–405. CrossRef
- Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology. 2004;126:1593–610. CrossRef
- Complicated granulomatous colitis in a Japanese patient with Hermansky–Pudlak syndrome, successfully treated with infliximab
Clinical Journal of Gastroenterology
Volume 2, Issue 1 , pp 51-54
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Hermansky–Pudlak syndrome
- Granulomatous colitis
- Author Affiliations
- 1. Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan